Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia

Tekijä Tannous, Abla, Levinson, Susan L., Bolognese, James, Opal, Steven M., DiNubile, Mark J.
Julkaisussa Antimicrob Agents Chemother (2020)

Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

Tekijä DiNubile, Mark J, Levinson, Susan L, Stossel, Thomas P, Lawrenz, Matthew B, Warawa, Jonathan M
Julkaisussa Open Forum Infect Dis (2020)

Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes

Tekijä Self, Wesley H, Wunderink, Richard G, DiNubile, Mark J, Stossel, Thomas P, Levinson, Susan L, Williams, Derek J, Anderson, Evan J, Bramley, Anna M, Jain, Seema, Edwards, Kathryn M, Grijalva, Carlos G
Julkaisussa Clin Infect Dis (2019)

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Tekijä Abers, Michael S., Delmonte, Ottavia M., Ricotta, Emily E., Fintzi, Jonathan, Fink, Danielle L., de Jesus, Adriana A. Almeida, Zarember, Kol A., Alehashemi, Sara, Oikonomou, Vasileios, Desai, Jigar V., Canna, Scott W., Shakoory, Bita, Dobbs, Kerry, Imberti, Luisa, Sottini, Alessandra, Quiros-Roldan, Eugenia, Castelli, Francesco, Rossi, Camillo, Brugnoni, Duilio, Biondi, Andrea, Bettini, Laura Rachele, D’Angio’, Mariella, Bonfanti, Paolo, Castagnoli, Riccardo, Montagna, Daniela, Licari, Amelia, Marseglia, Gian Luigi, Gliniewicz, Emily F., Shaw, Elana, Kahle, Dana E., Rastegar, Andre T., Stack, Michael, Myint-Hpu, Katherine, Levinson, Susan L., DiNubile, Mark J., Chertow, Daniel W., Burbelo, Peter D., Cohen, Jeffrey I., Calvo, Katherine R., Tsang, John S., Su, Helen C., Gallin, John I., Kuhns, Douglas B., Goldbach-Mansky, Raphaela, Lionakis, Michail S., Notarangelo, Luigi D.
Julkaisussa JCI Insight (2021)